Log in to save to my catalogue

EZH2 and POU2F3 Can Aid in the Distinction of Thymic Carcinoma from Thymoma

EZH2 and POU2F3 Can Aid in the Distinction of Thymic Carcinoma from Thymoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10137080

EZH2 and POU2F3 Can Aid in the Distinction of Thymic Carcinoma from Thymoma

About this item

Full title

EZH2 and POU2F3 Can Aid in the Distinction of Thymic Carcinoma from Thymoma

Publisher

Switzerland: MDPI AG

Journal title

Cancers, 2023-04, Vol.15 (8), p.2274

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Thymic carcinoma is an aggressive malignancy that can be challenging to distinguish from thymoma using histomorphology. We assessed two emerging markers for these entities, EZH2 and POU2F3, and compared them with conventional immunostains. Whole slide sections of 37 thymic carcinomas, 23 type A thymomas, 13 type B3 thymomas, and 8 micronodular thym...

Alternative Titles

Full title

EZH2 and POU2F3 Can Aid in the Distinction of Thymic Carcinoma from Thymoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10137080

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10137080

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers15082274

How to access this item